RNA - Avidity Biosciences - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart

RNA is currently covered by 3 analysts with an average price target of $22.5. This is a potential upside of $15.58 (225.14%) from yesterday's end of day stock price of $6.92.

Avidity Biosciences's activity chart (see below) currently has 4 price targets and 8 ratings on display. The stock rating distribution of RNA is 80% BUY and 20% HOLD.

Stock Analyst Price Targets - Review

Highest price target for RNA is $25, Lowest price target is $20, average price target is $22.5.

Most recent stock forecast was given by MITCHELL KAPOOR from HC WAINWRIGHT on 28-Oct-2026. First documented stock forecast 09-Nov-2023.

Best performing analysts who are covering RNA - Avidity Biosciences:

Joseph Schwartz Ananda Ghosh Mitchell Kapoor

Currently out of the existing stock ratings of RNA, 1 are a HOLD (20%), 4 are a BUY (80%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 06-Aug-2026

$20

$13.08 (189.02%)

$25

25 days ago
(28-Oct-2026)

0/3 (0%)

$11.6 (138.10%)

Buy Since 09-Nov-2023

$25

$18.08 (261.27%)

$18

6 months 7 days ago
(15-May-2026)

0/2 (0%)

$11.77 (88.96%)

Hold Since 01-May-2026

$72

6 months 21 days ago
(01-May-2026)

0/2 (0%)

$72 (0.00%)

Show more analysts

Please expand the browser size to see the chart

Which analyst most recently updated their price target on RNA (Avidity Biosciences)?

Mitchell Kapoor

Which analyst has the lowest performance score on RNA (Avidity Biosciences) with a proven track record?

MITCHELL KAPOOR

Which analyst has the most public recommendations on RNA (Avidity Biosciences)?

Mitchell Kapoor works at HC WAINWRIGHT and has 9 price targets and 7 ratings on RNA

Which analyst is the currently most bullish on RNA (Avidity Biosciences)?

Joseph Schwartz with the highest potential upside of $18.08

Which analyst is the currently most reserved on RNA (Avidity Biosciences)?

Ananda Ghosh with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?